lansoprazole has been researched along with dinoprostone in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Arakawa, T; Fukuda, T; Higuchi, K; Kobayashi, K; Nakamura, H | 1 |
| Hori, M; Kakiuchi, Y; Kawai, N; Kawano, S; Kimura, A; Komori, M; Murata, H; Sasaki, Y; Sun, WH; Tsuji, S; Tsujii, M; Yasumaru, S | 1 |
| Razmilic, I; Rodríguez, JA; Sánchez, M; Schmeda-Hirschmann, G; Theoduloz, C; Yáñez, T | 2 |
| Areche, C; Barbastefano, V; de Paula, D; Ferreira, AL; Rodríguez, JA; Schmeda-Hirschmann, G; Souza-Brito, AR; Theoduloz, C; Yáñez, T | 1 |
| Antonioli, L; Awwad, O; Basolo, F; Blandizzi, C; Colucci, R; Fornai, M; Fulceri, F; Natale, G; Tuccori, M; Ugolini, C | 1 |
| Arai, Y; Hiraoka, N; Inoue, H; Kishida, T; Kubo, T; Mazda, O; Nakagawa, S; Sakai, R; Tsuchida, S | 1 |
| Angioli, R; Damiani, P; Improta, G; Petrella, C; Plotti, F; Scarpignato, C; Severini, C; Signore, F; Terranova, C | 1 |
1 trial(s) available for lansoprazole and dinoprostone
| Article | Year |
|---|---|
H2-receptor antagonist-refractory ulcer: its pathophysiology and treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Dinoprostone; Female; Gastric Mucosa; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Misoprostol; Omeprazole; Peptic Ulcer; Wound Healing | 1991 |
8 other study(ies) available for lansoprazole and dinoprostone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Lansoprazole induces mucosal protection through gastrin receptor-dependent up-regulation of cyclooxygenase-2 in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Ethanol; Gastric Mucosa; Isoenzymes; Lansoprazole; Male; Omeprazole; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Stomach Ulcer; Up-Regulation | 2002 |
Gastroprotective activity of a new semi-synthetic solidagenone derivative in mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Animals; Anti-Ulcer Agents; Cell Line; Cell Proliferation; Chile; Dinoprostone; Disease Models, Animal; Diterpenes; Drug Evaluation, Preclinical; Epithelium; Ethanol; Fibroblasts; Furans; Gastric Mucosa; Humans; Hydrochloric Acid; Inhibitory Concentration 50; Lansoprazole; Lung; Mice; Naphthalenes; Neutral Red; Omeprazole; Stomach Ulcer; Tetrazolium Salts | 2005 |
Gastroprotective and ulcer-healing activity of oleanolic acid derivatives: in vitro-in vivo relationships.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Cell Line; Cell Proliferation; Cell Survival; Central Nervous System Depressants; Chemical Phenomena; Chemistry, Physical; Dinoprostone; Epithelial Cells; Ethanol; Fibroblasts; Free Radical Scavengers; Gastric Mucosa; Glutathione; Humans; Hydrochloric Acid; Lansoprazole; Male; Mice; Oleanolic Acid; Omeprazole; Stomach Ulcer; Superoxides; Taurocholic Acid | 2006 |
Gastroprotective activity of ferruginol in mice and rats: effects on gastric secretion, endogenous prostaglandins and non-protein sulfhydryls.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Administration, Oral; Animals; Anti-Ulcer Agents; Dinoprostone; Dose-Response Relationship, Drug; Ethanol; Gastric Juice; Gastric Mucosa; Glutathione; Lansoprazole; Male; Mice; Rats; Rats, Wistar; Sulfhydryl Compounds; Toxicity Tests, Acute | 2008 |
Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanisms.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Apoptosis; Blotting, Western; Caspase 3; Cell Proliferation; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Esomeprazole; Famotidine; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; Immunohistochemistry; Indomethacin; Ki-67 Antigen; Lansoprazole; Male; Malondialdehyde; Proliferating Cell Nuclear Antigen; Proton Pump Inhibitors; Rats; Rats, Wistar; Stomach Ulcer; Time Factors; Vascular Endothelial Growth Factor A; Wound Healing | 2011 |
Lansoprazole inhibits nitric oxide and prostaglandin E(2) production in murine macrophage RAW 264.7 cells.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents; Cell Line; Dinoprostone; Enzyme Inhibitors; Inflammation; Lansoprazole; Lipopolysaccharides; Macrophages; Mice; NADPH Oxidases; Nitric Oxide; Onium Compounds; Proton Pump Inhibitors; Reactive Oxygen Species | 2012 |
Relaxant effect of proton pump inhibitors on in vitro myometrium from pregnant women.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Apamin; Calcium; Dinoprostone; Esomeprazole; Female; Humans; In Vitro Techniques; Indomethacin; Lansoprazole; Muscle Contraction; Myometrium; NG-Nitroarginine Methyl Ester; Omeprazole; Oxytocin; Pantoprazole; Peptides; Potassium Chloride; Pregnancy; Proton Pump Inhibitors; Rabeprazole; Tocolytic Agents | 2014 |